175 related articles for article (PubMed ID: 33247941)
1. Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammation.
Sakai K; Noguchi-Shinohara M; Ikeda T; Hamaguchi T; Ono K; Yamada M
Acta Neurol Scand; 2021 Apr; 143(4):450-457. PubMed ID: 33247941
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
5. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.
Piazza F; Greenberg SM; Savoiardo M; Gardinetti M; Chiapparini L; Raicher I; Nitrini R; Sakaguchi H; Brioschi M; Billo G; Colombo A; Lanzani F; Piscosquito G; Carriero MR; Giaccone G; Tagliavini F; Ferrarese C; DiFrancesco JC
Ann Neurol; 2013 Apr; 73(4):449-58. PubMed ID: 23625526
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation.
Kimura A; Sakurai T; Yoshikura N; Hayashi Y; Takemura M; Takahashi H; Inuzuka T
J Neuroinflammation; 2013 Mar; 10():39. PubMed ID: 23497126
[TBL] [Abstract][Full Text] [Related]
7. Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.
Vervuurt M; de Kort AM; Jäkel L; Kersten I; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Verbeek MM
Alzheimers Res Ther; 2023 Jan; 15(1):26. PubMed ID: 36717932
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral Amyloid Angiopathy-Related Inflammation/Vasculitis].
Sakai K; Yamada M
Brain Nerve; 2021 May; 73(5):489-495. PubMed ID: 34006680
[TBL] [Abstract][Full Text] [Related]
9. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij BH; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
[TBL] [Abstract][Full Text] [Related]
10. Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy.
Jäkel L; De Kort AM; Stellingwerf A; Hernández Utrilla C; Kersten I; Vervuurt M; Vermeiren Y; Küsters B; Schreuder FHBM; Klijn CJM; Kuiperij HB; Verbeek MM
Acta Neuropathol Commun; 2024 Jun; 12(1):103. PubMed ID: 38915119
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related Inflammation.
Plotzker AS; Henson RL; Fagan AM; Morris JC; Day GS
J Alzheimers Dis; 2021; 80(1):133-142. PubMed ID: 33492294
[TBL] [Abstract][Full Text] [Related]
13. Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience.
Salvarani C; Morris JM; Giannini C; Brown RD; Christianson T; Hunder GG
Medicine (Baltimore); 2016 May; 95(20):e3613. PubMed ID: 27196463
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
15. Different clinical outcomes between cerebral amyloid angiopathy-related inflammation and non-inflammatory form.
Grangeon L; Quesney G; Verdalle-Cazes M; Coulette S; Renard D; Wacongne A; Allou T; Olivier N; Boukriche Y; Blanchet-Fourcade G; Labauge P; Arquizan C; Canaple S; Godefroy O; Martinaud O; Verdure P; Quillard-Muraine M; Pariente J; Magnin E; Nicolas G; Charbonnier C; Maltête D; Formaglio M; Raposo N; Ayrignac X; Wallon D
J Neurol; 2022 Sep; 269(9):4972-4984. PubMed ID: 35752990
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Carmona-Iragui M; Fernández-Arcos A; Alcolea D; Piazza F; Morenas-Rodriguez E; Antón-Aguirre S; Sala I; Clarimon J; Dols-Icardo O; Camacho V; Sampedro F; Munuera J; Nuñez-Marin F; Lleó A; Fortea J; Gómez-Ansón B; Blesa R
J Alzheimers Dis; 2016; 50(1):1-7. PubMed ID: 26639966
[TBL] [Abstract][Full Text] [Related]
17. Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: A systematic analysis of published and seven new cases.
Szalardy L; Fakan B; Maszlag-Torok R; Ferencz E; Reisz Z; Radics BL; Csizmadia S; Szpisjak L; Annus A; Zadori D; Kovacs GG; Klivenyi P
Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12946. PubMed ID: 38093468
[TBL] [Abstract][Full Text] [Related]
18. Cerebral amyloid angiopathy-related inflammation: current status and future implications.
Wu JJ; Yao M; Ni J
Chin Med J (Engl); 2021 Feb; 134(6):646-654. PubMed ID: 33625036
[TBL] [Abstract][Full Text] [Related]
19. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
[TBL] [Abstract][Full Text] [Related]
20. Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.
Boncoraglio GB; Piazza F; Savoiardo M; Farina L; DiFrancesco JC; Prioni S; Tagliavini F; Parati EA; Giaccone G
J Alzheimers Dis; 2015; 45(2):363-7. PubMed ID: 25537009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
